Actively Recruiting
Blood Flow Restriction for Upper Limb Rehabilitation in People With Multiple Sclerosis. A Randomized Controlled Trial (BFRT-EM)
Led by Universidad Rey Juan Carlos · Updated on 2026-04-29
20
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Although the Blood Flow Restriction Training (BFRT) system has attracted the attention of health professionals, research on this tool in people with neurological pathology, particularly multiple sclerosis (MS), is very limited. Furthermore, to our knowledge, studies on the effect of the BFRT system on forearm-hand muscle strength and fatigability, coordination and dexterity, functionality and quality of life in people with MS are nonexistent. The main objective of our study are: -To know the effects of low intensity training in combination with the BFRT system on upper limb strength and forearm and hand fatigability, dexterity, functionality and quality of life in people with MS. Secondary Objectives * To know if a low-intensity muscle strengthening program in combination with the BFRT system is superior to a conventional strengthening program. * To know the adherence and satisfaction with the experimental intervention. The investigators propose to conduct a randomized controlled trial (RCT) with examiner blinding with pre-intervention, post-intervention and follow-up assessment, following the recommendations of the CONSORT guidelines, designed to study the effects of the application of a low-intensity muscle strengthening program in combination with the BFRT system. This intervention will be carried out at the Leganés Multiple Sclerosis Association (ALEM). Patients will be randomly assigned through the GraphPad Software® QuickCalcs application to 2 study groups. A control group, which will receive a low intensity strengthening program in combination with the BFRT system; and an experimental group, which will receive a high intensity strengthening program. Voluntary participation will be requested from patients diagnosed with MS in the Leganés Multiple Sclerosis Association (ALEM) who meet the inclusion criteria. Acceptance of the study and signature of the informed consent form will be required prior to the start of the program. As this is the first study to evaluate the effectiveness and feasibility of a low-intensity muscle strengthening protocol in combination with BFRT on forearm and hand muscle strength and fatigability, coordination, dexterity, functionality and quality of life in people with MS, the sample size will be determined based on the most similar scientific literature possible. Hill et al developed an investigation comparing the adaptations of MS patients to two types of intervention: high intensity or conventional strengthening program versus low intensity in combination with BFRT. Since this is the only investigation to date that includes MMSS exercises in their intervention, we consider that the sample size proposed by Hill et al is the most appropriate for our investigation. The sample size obtained in that investigation was 19 subjects, so for the sample size of the present investigation a total of 19 subjects is proposed. However, estimating a 10% possible percentage of losses, we estimate a total of 21 total participants to be recruited. Patients will be randomly assigned via the GraphPad Software® QuickCalcs application to 2 study groups. A control group, which will receive a low-intensity strengthening program in combination with the BFRT system; and an experimental group, which will receive a high-intensity strengthening program.
CONDITIONS
Official Title
Blood Flow Restriction for Upper Limb Rehabilitation in People With Multiple Sclerosis. A Randomized Controlled Trial (BFRT-EM)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years of age
- Diagnosed with multiple sclerosis according to McDonald criteria for more than two years
- EDSS score between 2.0 and 7.0
- Stable medical treatment for at least six months before the study
- Upper limb muscle tone no higher than 2 points on the modified Ashworth Scale
- Muscle strength of 3 or more in the upper limb
- Pyramidal Function score of 4 or less on the EDSS
- No cognitive impairment; able to understand instructions and scoring 24 or higher on the Minimental Test
- Mental Functions score of 2 or less on the EDSS
You will not qualify if you...
- Diagnosed with any neurological or musculoskeletal disease other than multiple sclerosis
- Diagnosed with cardiovascular, respiratory, metabolic, or other diseases that may interfere with the study
- Experienced exacerbation or hospitalization in the last 3 months before or during the study
- Received steroids (intravenous or oral) in the 6 months before or during the study
- Received botulinum toxin treatment within 6 months before the study
- Muscle tone higher than 2 points on the modified Ashworth Scale
- Cognitive or language impairments preventing proper communication or understanding
- History of deep vein thrombosis, pulmonary embolism, vascular disease, thrombophilia, or any blood circulation or clotting disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asociación de Leganés de Esclerosis Múltiple
Leganés, Madrid, Spain, 28922
Actively Recruiting
Research Team
R
Roberto Cano de la Cuerda, PT, PhD
CONTACT
A
Aitor Blázquez Fernández, PT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here